
|Articles|May 19, 2010
What's Race & Ethnicity Got To Do With It? For Insulin Regimens, A Lot
Is a once daily dose of insulin glargine or NPH the best treatment strategy for patients who are of Latino/Hispanic descent? Which ethnicity responds best to a lispro mix of 75/25 twice daily? With the brunt of type 2 diabetes affecting non-Caucasian populations, researchers shed light on treatment strategy efficacy across races and ethnicities.
Advertisement
Is a once daily dose of insulin glargine or NPH the best treatment strategy for patients who are of Latino/Hispanic descent? Which ethnicity responds best to a lispro mix of 75/25 twice daily? With the brunt of type 2 diabetes affecting non-Caucasian populations, researchers shed light on treatment strategy efficacy across races and ethnicities.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Once-Weekly Insulin Icodec Offers a Major Shift in Type 2 Diabetes Care
2
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva
3
Dementia Prevention Research Expands Beyond Traditional Vascular Risk Factors
4
FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication
5








































































































































